<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24(6)</volume><submitter>Cao SJ</submitter><pubmed_abstract>Regulator of G-protein signaling 22 (RGS22) is specifically expressed in the testis and in tumors of epithelial origin, but the expression and role of RGS22 in pancreatic cancer are unclear. In this study, 52 pairs of pancreatic ductal adenocarcinoma (PDAC) and adjacent non-neoplastic tissue samples with the corresponding clinical data were used to examine the expression of RGS22 and its relationship with PDAC prognosis. The findings showed that the expression of RGS22 was higher in the PDAC tissues than in the adjacent non-tumorous tissues and its expression was associated with the degree of blood vessel invasion. The &lt;i>in vitro&lt;/i> experiments with PDAC cell lines and a normal control cell line showed that the proliferation, invasion, and metastasis of PDAC cells were suppressed by RGS2</pubmed_abstract><journal>Oncology letters</journal><pagination>457</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9650600</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Suppressive effect of YY1-mediated RGS22 regulation on the proliferation, migration and invasion of pancreatic ductal adenocarcinoma.</pubmed_title><pmcid>PMC9650600</pmcid><pubmed_authors>Ge WL</pubmed_authors><pubmed_authors>Meng LD</pubmed_authors><pubmed_authors>Zhang JJ</pubmed_authors><pubmed_authors>Chen Q</pubmed_authors><pubmed_authors>Jiang KR</pubmed_authors><pubmed_authors>Cao SJ</pubmed_authors><pubmed_authors>Miao Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Suppressive effect of YY1-mediated RGS22 regulation on the proliferation, migration and invasion of pancreatic ductal adenocarcinoma.</name><description>Regulator of G-protein signaling 22 (RGS22) is specifically expressed in the testis and in tumors of epithelial origin, but the expression and role of RGS22 in pancreatic cancer are unclear. In this study, 52 pairs of pancreatic ductal adenocarcinoma (PDAC) and adjacent non-neoplastic tissue samples with the corresponding clinical data were used to examine the expression of RGS22 and its relationship with PDAC prognosis. The findings showed that the expression of RGS22 was higher in the PDAC tissues than in the adjacent non-tumorous tissues and its expression was associated with the degree of blood vessel invasion. The &lt;i>in vitro&lt;/i> experiments with PDAC cell lines and a normal control cell line showed that the proliferation, invasion, and metastasis of PDAC cells were suppressed by RGS2</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2025-04-05T11:36:18.36Z</modification><creation>2025-04-05T11:36:18.36Z</creation></dates><accession>S-EPMC9650600</accession><cross_references><pubmed>36380881</pubmed><doi>10.3892/ol.2022.13577</doi></cross_references></HashMap>